Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Finance

Sophia aims to parlay expertise of new backers aMoon, Hitachi to grow biopharma business

Swiss genomics company raises $110M in series F round

By Paul Bonanos, Associate Editor, and Jeff Cranmer, Executive editor
October 2, 2020 1:37 AM UTC

Genomics data company Sophia looked increasingly to healthcare investors when putting together the syndicate for its new $110 million series F round, which will go toward building the biopharma side of its business.

Sophia Genetics S.A. had largely been funded by tech investors, founder and CEO Jurgi Camblong told BioCentury. “For this round, we wanted to bring in healthcare investors who know the space, as well as who know strategic angles in that space.”...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Sophia Genetics S.A.